brimonidine

FDA Drug Profile — BRIMONIDINE

brimonidine is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including BRIMONIDINE. Available dosage form: gel.

Drug details

Generic Name
brimonidine
Brand Names
BRIMONIDINE
Application Number
ANDA209158
Sponsor
Bryant Ranch Prepack
NDC Codes
2
Dosage Forms
GEL
Routes
TOPICAL
Active Ingredients
BRIMONIDINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Brimonidine topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) erythema of rosacea in adults 18 years of age or older. Brimonidine topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.